Christine L. Chung

2021

In 2021, Christine L. Chung earned a total compensation of $4.7M as Senior Vice President, China Operations at FibroGen, a 64% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$180,707
Option Awards$2,031,863
Salary$490,000
Stock Awards$1,688,225
Other$336,349
Total$4,727,144

Chung received $2M in option awards, accounting for 43% of the total pay in 2021.

Chung also received $180.7K in non-equity incentive plan, $490K in salary, $1.7M in stock awards and $336.3K in other compensation.

Rankings

In 2021, Christine L. Chung's compensation ranked 2,794th out of 12,415 executives tracked by ExecPay. In other words, Chung earned more than 77.5% of executives.

ClassificationRankingPercentile
All
2,794
out of 12,415
78th
Division
Manufacturing
1,106
out of 5,505
80th
Major group
Chemicals And Allied Products
437
out of 2,375
82nd
Industry group
Drugs
381
out of 2,096
82nd
Industry
Pharmaceutical Preparations
255
out of 1,546
84th

Pay ratio

Christine L. Chung's Pay$4,727,144
Median Employee's Pay$174,414
Pay Ratio

27

to 1

In 2021, the annual total compensation of Christine L. Chung was $4,727,144.

The annual total compensation of the median employee at FibroGen was $174,414.

The ratio of Christine L. Chung's pay to the pay of median employee was therefore 27 to one.

Source: SEC filing on April 28, 2022.

Chung's colleagues

We found six more compensation records of executives who worked with Christine L. Chung at FibroGen in 2021.

2021

Enrique Conterno

FibroGen

Chief Executive Officer

2021

Mark Eisner

FibroGen

Chief Medical Officer

2021

Pat Cotroneo

FibroGen

Chief Financial Officer

2021

Elias Kouchakji

FibroGen

Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance

2021

Thane Wettig

FibroGen

Chief Commercial Officer

2021

Juan Graham

FibroGen

Chief Financial Officer

News

You may also like